{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:56:30Z","timestamp":1784231790237,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,23]]},"DOI":"10.7759\/cureus.58867","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:39:16Z","timestamp":1713933556000},"source":"Crossref","is-referenced-by-count":8,"title":["Vogt-Koyanagi-Harada Disease: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Ayushi","family":"Tayal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Daigavane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.01.046","article-title":"Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease","volume":"139","author":"Kitamura M","year":"2005","unstructured":"Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S. Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease. Am J Ophthalmol. 2005, 139:1080-5. 10.1016\/j.ajo.2005.01.046","journal-title":"Am J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12009-001-0071-4","article-title":"Eales' disease","author":"Gieser AS","year":"1994","unstructured":"Gieser AS, Murphy RP. Eales' disease. Retina, 2nd edition. Ryan SJ (ed): CV Mosby, St. Louis; 1994. 1503-7. 10.1007\/s12009-001-0071-4"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S94866","article-title":"Vogt-Koyanagi-Harada syndrome - current perspectives","volume":"10","author":"Baltmr A","year":"2016","unstructured":"Baltmr A, Lightman S, Tomkins-Netzer O. Vogt-Koyanagi-Harada syndrome - current perspectives. Clin Ophthalmol. 2016, 10:2345-61. 10.2147\/OPTH.S94866","journal-title":"Clin Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1192-0","article-title":"A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl","volume":"19","author":"Katsuyama A","year":"2019","unstructured":"Katsuyama A, Kusuhara S, Awano H, Nagase H, Matsumiya W, Nakamura M. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl. BMC Ophthalmol. 2019, 19:179. 10.1186\/s12886-019-1192-0","journal-title":"BMC Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0412-4","article-title":"Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes","volume":"11","author":"Lavezzo MM","year":"2016","unstructured":"Lavezzo MM, Sakata VM, Morita C, et al.. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016, 11:29. 10.1186\/s13023-016-0412-4","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01573-3","article-title":"Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review","volume":"36","author":"Herbort CP Jr","year":"2022","unstructured":"Herbort CP Jr, Tugal-Tutkun I, Abu-El-Asrar A, et al.. Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review. Eye (Lond). 2022, 36:29-43. 10.1038\/s41433-021-01573-3","journal-title":"Eye (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(77)90623-7","article-title":"Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome","volume":"83","author":"Perry HD","year":"1977","unstructured":"Perry HD, Font RL. Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1977, 83:242-54. 10.1016\/0002-9394(77)90623-7","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-006-9029-2","article-title":"Pathology of Vogt-Koyanagi-Harada disease","volume":"27","author":"Rao NA","year":"2007","unstructured":"Rao NA. Pathology of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007, 27:81-5. 10.1007\/s10792-006-9029-2","journal-title":"Int Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00851-5","article-title":"Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease","volume":"131","author":"Inomata H","year":"2001","unstructured":"Inomata H, Rao NA. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001, 131:607-14. 10.1016\/S0002-9394(00)00851-5","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.5604","article-title":"Choroidal hyperreflective foci in Stargardt disease shown by spectral-domain optical coherence tomography imaging: correlation with disease severity","volume":"133","author":"Piri N","year":"2015","unstructured":"Piri N, Nesmith BL, Schaal S. Choroidal hyperreflective foci in Stargardt disease shown by spectral-domain optical coherence tomography imaging: correlation with disease severity. JAMA Ophthalmol. 2015, 133:398-405. 10.1001\/jamaophthalmol.2014.5604","journal-title":"JAMA Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/APO.0000000000000249","article-title":"Choroidal hyperreflective foci: a novel spectral domain optical coherence tomography biomarker in eyes with diabetic macular edema","volume":"8","author":"Roy R","year":"2019","unstructured":"Roy R, Saurabh K, Shah D, Chowdhury M, Goel S. Choroidal hyperreflective foci: a novel spectral domain optical coherence tomography biomarker in eyes with diabetic macular edema. Asia Pac J Ophthalmol (Phila). 2019, 8:314-8. 10.1097\/APO.0000000000000249","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002645","article-title":"Hyperreflective foci as a pathogenetic biomarker in choroideremia","volume":"40","author":"Romano F","year":"2020","unstructured":"Romano F, Arrigo A, MacLaren RE, Charbel Issa P, Birtel J, Bandello F, Battaglia Parodi M. Hyperreflective foci as a pathogenetic biomarker in choroideremia. Retina. 2020, 40:1634-40. 10.1097\/IAE.0000000000002645","journal-title":"Retina"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000342159","article-title":"Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration","volume":"229","author":"Coscas G","year":"2013","unstructured":"Coscas G, De Benedetto U, Coscas F, et al.. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica. 2013, 229:32-7. 10.1159\/000342159","journal-title":"Ophthalmologica"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.10.2","article-title":"Macrophage-like cell density Is increased in proliferative diabetic retinopathy characterized by optical coherence tomography angiography","volume":"62","author":"Ong JX","year":"2021","unstructured":"Ong JX, Nesper PL, Fawzi AA, Wang JM, Lavine JA. Macrophage-like cell density Is increased in proliferative diabetic retinopathy characterized by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2021, 62:2. 10.1167\/iovs.62.10.2","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206482","article-title":"Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema","volume":"13","author":"Schreur V","year":"2018","unstructured":"Schreur V, Altay L, van Asten F, et al.. Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema. PLoS One. 2018, 13:e0206482. 10.1371\/journal.pone.0206482","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05469-6","article-title":"Hyperreflective foci in the choroid of normal eyes","volume":"260","author":"Kim YH","year":"2022","unstructured":"Kim YH, Oh J. Hyperreflective foci in the choroid of normal eyes. Graefes Arch Clin Exp Ophthalmol. 2022, 260:759-69. 10.1007\/s00417-021-05469-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/qims-21-637","article-title":"Comparison of choroidal hyperreflective spots on optical coherence tomography images between both eyes of normal subjects","volume":"12","author":"Kim YH","year":"2022","unstructured":"Kim YH, Oh J. Comparison of choroidal hyperreflective spots on optical coherence tomography images between both eyes of normal subjects. Quant Imaging Med Surg. 2022, 12:920-35. 10.21037\/qims-21-637","journal-title":"Quant Imaging Med Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/02713689008999417","article-title":"Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus","volume":"9","author":"Inomata H","year":"1990","unstructured":"Inomata H, Sakamoto T. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res. 1990, 9:35-40. 10.3109\/02713689008999417","journal-title":"Curr Eye Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2020.12.13","article-title":"Melanin change of retinal pigment epithelium and choroid in the convalescent stage of Vogt-Koyanagi-Harada disease","volume":"13","author":"Huang Y","year":"2020","unstructured":"Huang Y, Yang YT, Lin B, et al.. Melanin change of retinal pigment epithelium and choroid in the convalescent stage of Vogt-Koyanagi-Harada disease. Int J Ophthalmol. 2020, 13:1928-32. 10.18240\/ijo.2020.12.13","journal-title":"Int J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-016-0395-0","article-title":"Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality","volume":"37","author":"Herbort CP Jr","year":"2017","unstructured":"Herbort CP Jr, Abu El Asrar AM, Yamamoto JH, et al.. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality. Int Ophthalmol. 2017, 37:1383-95. 10.1007\/s10792-016-0395-0","journal-title":"Int Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-018-0949-4","article-title":"Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease","volume":"39","author":"Herbort CP Jr","year":"2019","unstructured":"Herbort CP Jr, Abu El Asrar AM, Takeuchi M, et al.. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease. Int Ophthalmol. 2019, 39:1419-25. 10.1007\/s10792-018-0949-4","journal-title":"Int Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00937-0","article-title":"Complications and prognostic factors in Vogt-Koyanagi-Harada disease","volume":"131","author":"Read RW","year":"2001","unstructured":"Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001, 131:599-606. 10.1016\/S0002-9394(01)00937-0","journal-title":"Am J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12127","article-title":"Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids","volume":"91","author":"Abu El-Asrar AM","year":"2013","unstructured":"Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013, 91:e486-93. 10.1111\/aos.12127","journal-title":"Acta Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-014-2904-z","article-title":"High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids","volume":"253","author":"Sakata VM","year":"2015","unstructured":"Sakata VM, da Silva FT, Hirata CE, et al.. High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. Graefes Arch Clin Exp Ophthalmol. 2015, 253:785-90. 10.1007\/s00417-014-2904-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-020-01417-1","article-title":"Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area","volume":"40","author":"Herbort CP Jr","year":"2020","unstructured":"Herbort CP Jr, Tugal-Tutkun I, Khairallah M, Abu El Asrar AM, Pav\u00e9sio CE, Soheilian M. Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area. Int Ophthalmol. 2020, 40:2423-33. 10.1007\/s10792-020-01417-1","journal-title":"Int Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(05)80105-5","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"39","author":"Moorthy RS","year":"1995","unstructured":"Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995, 39:265-92. 10.1016\/s0039-6257(05)80105-5","journal-title":"Surv Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.78.3.223","article-title":"HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410","volume":"78","author":"Shindo Y","year":"1994","unstructured":"Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol. 1994, 78:223-6. 10.1136\/bjo.78.3.223","journal-title":"Br J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1996.tb02565.x","article-title":"A significant association of HLA-DPB1*0501 with Vogt-Koyanagi-Harada's disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405","volume":"47","author":"Shindo Y","year":"1996","unstructured":"Shindo Y, Ohno S, Nakamura S, Ono\u00e9 K, Inoko H. A significant association of HLA-DPB1*0501 with Vogt-Koyanagi-Harada's disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405. Tissue Antigens. 1996, 47:344-5. 10.1111\/j.1399-0039.1996.tb02565.x","journal-title":"Tissue Antigens"},{"key":"ref29","article-title":"Vogt-Koyanagi-Harada disease","volume":"22","author":"Sigiura S","year":"1978","unstructured":"Sigiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978, 22:229-42.","journal-title":"Jpn J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.023","article-title":"Diagnosis and classification of Vogt-Koyanagi-Harada disease","volume":"13","author":"Sakata VM","year":"2014","unstructured":"Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev. 2014, 13:550-5. 10.1016\/j.autrev.2014.01.023","journal-title":"Autoimmun Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-006-9024-7","article-title":"Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease","volume":"27","author":"Fardeau C","year":"2007","unstructured":"Fardeau C, Tran TH, Gharbi B, Cassoux N, Bodaghi B, LeHoang P. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007, 27:163-72. 10.1007\/s10792-006-9024-7","journal-title":"Int Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-006-9027-4","article-title":"Fluorescein fundus angiographic findings in Vogt-Koyanagi-Harada syndrome","volume":"27","author":"Arellanes-Garc\u00eda L","year":"2007","unstructured":"Arellanes-Garc\u00eda L, Hern\u00e1ndez-Barrios M, Fromow-Guerra J, Cervantes-Fanning P. Fluorescein fundus angiographic findings in Vogt-Koyanagi-Harada syndrome. Int Ophthalmol. 2007, 27:155-61. 10.1007\/s10792-006-9027-4","journal-title":"Int Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01563-4","article-title":"Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update","volume":"110","author":"Stanga PE","year":"2003","unstructured":"Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology. 2003, 110:15-21. 10.1016\/S0161-6420(02)01563-4","journal-title":"Ophthalmology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.002","article-title":"Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography","volume":"116","author":"Ishihara K","year":"2009","unstructured":"Ishihara K, Hangai M, Kita M, Yoshimura N. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography. Ophthalmology. 2009, 116:1799-807. 10.1016\/j.ophtha.2009.04.002","journal-title":"Ophthalmology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-301857","article-title":"Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease","volume":"96","author":"Nazari H","year":"2012","unstructured":"Nazari H, Rao NA. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2012, 96:1410-4. 10.1136\/bjophthalmol-2012-301857","journal-title":"Br J Ophthalmol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S1001-9294(12)60019-4","article-title":"Spectral domain optical coherence tomography of Vogt-Koyanagi-Harada disease: novel findings and new insights into the pathogenesis","volume":"27","author":"Zhao C","year":"2012","unstructured":"Zhao C, Zhang MF, Dong FT, et al.. Spectral domain optical coherence tomography of Vogt-Koyanagi-Harada disease: novel findings and new insights into the pathogenesis. Chin Med Sci J. 2012, 27:29-34. 10.1016\/S1001-9294(12)60019-4","journal-title":"Chin Med Sci J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181c5970d","article-title":"Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings","volume":"30","author":"Vasconcelos-Santos DV","year":"2010","unstructured":"Vasconcelos-Santos DV, Sohn EH, Sadda S, Rao NA. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings. Retina. 2010, 30:33-41. 10.1097\/IAE.0b013e3181c5970d","journal-title":"Retina"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.12.008","article-title":"A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes","volume":"147","author":"Margolis R","year":"2009","unstructured":"Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009, 147:811-5. 10.1016\/j.ajo.2008.12.008","journal-title":"Am J Ophthalmol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070120069031","article-title":"Echographic features of the Vogt-Koyanagi-Harada syndrome","volume":"108","author":"Forster DJ","year":"1990","unstructured":"Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol. 1990, 108:1421-6. 10.1001\/archopht.1990.01070120069031","journal-title":"Arch Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-1156-3","article-title":"Visual function in Vogt-Koyanagi-Harada patients","volume":"243","author":"Chee SP","year":"2005","unstructured":"Chee SP, Luu CD, Cheng CL, Lim WK, Jap A. Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol. 2005, 243:785-90. 10.1007\/s00417-005-1156-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.05.044","article-title":"Study of macular function by multifocal electroretinography in patients with Vogt-Koyanagi-Harada syndrome","volume":"146","author":"Yang P","year":"2008","unstructured":"Yang P, Fang W, Wang L, Wen F, Wu W, Kijlstra A. Study of macular function by multifocal electroretinography in patients with Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 2008, 146:767-71. 10.1016\/j.ajo.2008.05.044","journal-title":"Am J Ophthalmol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.89","article-title":"Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease","volume":"23","author":"Lai TY","year":"2009","unstructured":"Lai TY, Chan RP, Chan CK, Lam DS. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye. 2009, 23:543-8. 10.1038\/eye.2008.89","journal-title":"Eye"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(02)01117-x","article-title":"Corticosteroids and central serous chorioretinopathy","volume":"109","author":"Carvalho-Recchia CA","year":"2002","unstructured":"Carvalho-Recchia CA, Yannuzzi LA, Negr\u00e3o S, et al.. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002, 109:1834-7. 10.1016\/s0161-6420(02)01117-x","journal-title":"Ophthalmology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey PJ","year":"1999","unstructured":"McCluskey PJ, Watson PG, Lightman S, Haybittle J, Restori M, Branley M. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999, 106:2380-6. 10.1016\/S0161-6420(99)90543-2","journal-title":"Ophthalmology"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(88)90093-8","article-title":"Posterior scleritis","volume":"32","author":"Benson WE","year":"1988","unstructured":"Benson WE. Posterior scleritis. Surv Ophthalmol. 1988, 32:297-316. 10.1016\/0039-6257(88)90093-8","journal-title":"Surv Ophthalmol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181a0bd15","article-title":"Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis","volume":"29","author":"Fiore T","year":"2009","unstructured":"Fiore T, Iaccheri B, Androudi S, et al.. Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina. 2009, 29:994-1001. 10.1097\/IAE.0b013e3181a0bd15","journal-title":"Retina"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.4.384","article-title":"Acute posterior multifocal placoid pigment epitheliopathy","volume":"79","author":"Jones NP","year":"1995","unstructured":"Jones NP. Acute posterior multifocal placoid pigment epitheliopathy. Br J Ophthalmol. 1995, 79:384-9. 10.1136\/bjo.79.4.384","journal-title":"Br J Ophthalmol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/IIO.0b013e318265d45a","article-title":"Imaging in the diagnosis and management of APMPPE","volume":"52","author":"Steiner S","year":"2012","unstructured":"Steiner S, Goldstein DA. Imaging in the diagnosis and management of APMPPE. Int Ophthalmol Clin. 2012, 52:211-9. 10.1097\/IIO.0b013e318265d45a","journal-title":"Int Ophthalmol Clin"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.521610","article-title":"Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature","volume":"19","author":"Lee GE","year":"2011","unstructured":"Lee GE, Lee BW, Rao NA, Fawzi AA. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature. Ocul Immunol Inflamm. 2011, 19:42-7. 10.3109\/09273948.2010.521610","journal-title":"Ocul Immunol Inflamm"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2011.00668.x","article-title":"Subfoveal choroidal thickness in multiple evanescent white dot syndrome","volume":"95","author":"Aoyagi R","year":"2012","unstructured":"Aoyagi R, Hayashi T, Masai A, Mitooka K, Gekka T, Kozaki K, Tsuneoka H. Subfoveal choroidal thickness in multiple evanescent white dot syndrome. Clin Exp Optom. 2012, 95:212-7. 10.1111\/j.1444-0938.2011.00668.x","journal-title":"Clin Exp Optom"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.08.025","article-title":"Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference","volume":"141","author":"Levinson RD","year":"2006","unstructured":"Levinson RD, Brezin A, Rothova A, Accorinti M, Holland GN. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol. 2006, 141:185-7. 10.1016\/j.ajo.2005.08.025","journal-title":"Am J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235010-vogt-koyanagi-harada-disease-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:39:21Z","timestamp":1713933561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235010-vogt-koyanagi-harada-disease-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.58867","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}